Literature DB >> 1990552

Should cyclosporine be continued indefinitely?

C R Stiller1, G Opelz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1990552

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Daclizumab: a review of its use in the prevention of acute rejection in renal transplant recipients.

Authors:  L R Wiseman; D Faulds
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

Review 2.  Immunosuppressive drugs in renal transplantation. A review of the regimens.

Authors:  J M Barry
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 3.  Perspectives in transplantation immunology 1991.

Authors:  D Kabelitz; M L da Silva Lobo; K Pechhold
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 4.  Cyclosporin: a pharmacoeconomic evaluation of its use in renal transplantation.

Authors:  J E Frampton; D Faulds
Journal:  Pharmacoeconomics       Date:  1993-11       Impact factor: 4.981

Review 5.  Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.

Authors:  B Fulton; A Markham
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

6.  Chemical mutagenesis and high throughput media optimization in Tolypocladium inflatum MTCC-3538 leads to enhanced production of cyclosporine A.

Authors:  Vidushi Abrol; Manoj Kushwaha; Sharada Mallubhotla; Sundeep Jaglan
Journal:  3 Biotech       Date:  2022-07-05       Impact factor: 2.893

7.  Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.

Authors:  N R Sinclair
Journal:  CMAJ       Date:  1992-09-01       Impact factor: 8.262

8.  Kidney transplantation in type 1 (insulin-dependent) diabetic patients. Early glomerulopathy.

Authors:  R Osterby; G Nyberg; L Hedman; I Karlberg; H Persson; C Svalander
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

Review 9.  A review of assay methods for cyclosporin. Clinical implications.

Authors:  K T Kivistö
Journal:  Clin Pharmacokinet       Date:  1992-09       Impact factor: 6.447
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.